Pregnant or Breastfeeding Women: The safety of these peptides during pregnancy or breastfeeding has not been established, and therefore should be avoided by these populations
At least a dozen large drugmakers are set to roll out copies of Novo Nordisks blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires on Friday
Our professional staff will help you narrow down a treatment plan that works best for you
Billingham MEJ, Hicks C, Carney S
"For the newer GLP-1 medications, it would be useful to look at whether there are genetic variants, like the variants in PAM , that explain poor responders to their medications." "There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance." The research has been published in Genome Medicine .